GlaxoSmithKline has retained its top position among a global list of pharmaceutical companies striving to make their medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.
The 2018 Access to Medicine Index - which measures the performance of the top 20 pharma companies across seven different categories, such as access-to-medicine